Jack Hsiao
Director/Board Member at APPLIED BIOCODE CORPORATION
Jack Hsiao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED BIOCODE CORPORATION | Director/Board Member | 02/01/2018 | - |
| Independent Dir/Board Member | 02/01/2018 | - | |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - |
Career history of Jack Hsiao
Statistics
International
| United States | 2 |
| Taiwan | 2 |
Operational
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Electronic Technology | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| APPLIED BIOCODE CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
- Stock Market
- Insiders
- Jack Hsiao
- Experience
